Released on April 3rd, 2020
To our knowledge, there is currently no evidence on how and if Corona Virus Disease 2019 (COVID-19) affects people with rare neurological diseases, mainly neurogenetics (NGDs). A recent (April 3rd) research on PubMed did not… Continue Reading
EAN Congress 2025 relocated to HELSINKI due to UN summit (dates remain 21-24 June)
September 20, 2024
Due to unforeseen developments, the 11th Congress of the European Academy of Neurology has been relocated and will now be held in Helsinki on June 21-24, 2025.
EAN co-hosting G7 side-event in Ancona, Italy, on 8 October
September 13, 2024
Upcoming Joint Sessions at Partner Societies’ Congresses
August 26, 2024
Latest Posts
-
-
We are experiencing an unprecedented situation that no one had imagined or prepared for which has hit Europe during a period of prosperity, and the whole world. COVID-19 has come as a shock. In this context, headache services have to… Continue Reading
-
Neurologists stay aware of COVID-19 brain stem involvement The major clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection are due to pulmonary complications. The majority of the patients so far in the COVID-19 pandemic had milder symptoms… Continue Reading
-
Cutaneous silent periods Cutaneous silent period is a useful, although underestimated tool for the clinical assessment of poly neuropathy as well as other neurological condition. This review provides an up to date on the physiology and methodology for its use… Continue Reading
-
As the CoVID-19 pandemic spreads across Europe and the world, in response the European Academy of Neurology is launching EANcore CoVID-19. This resource aims to help neurologists in Europe and beyond prepare for and manage the challenges this global crisis is bringing.
-
The new Corona virus disease 2019 (COVID-19) has drastically changed the world as we know it. Every aspect of our lives has been modified to adapt ourselves and to prevent the spread of this novel coronavirus (SARS-CoV-2). According to the World Health Organization (WHO), 1 279 722 confirmed cases have been reported worldwide with more than 72 616 deaths (as of 7 April 2020). Africa is the least affected region (10,260 confirmed cases and 492 deaths). However, this number may be underestimated and is continuing to rise relentlessly. Thus, Africa is facing the biggest challenge of the 21st century: making health as a priority. Scientific societies, national and international health authorities have to work together to strengthen the fight against SARS-CoV-2 and COVID-19.
-
Neuromuscular patients management in the COVID era Neuromuscular diseases are a group of heterogenic rare conditions, that can be due to a genetic cause, inflammatory processes or dysimmune disorders. Pathogenic processes can affect motor neurons, peripheral nerves, neuromuscular junction, or… Continue Reading
-
Due to the CoVID-19 pandemic spread, most outpatient facilities have been strictly regulated, thus making it difficult for many patients suffering from chronic pain to access treatment. During this tough period, all pain physicians, including neurologists, are working to find… Continue Reading
-
EAN NewsCOVID-19Top Articles
EAN Movement Disorders Scientific Panel recommendations for COVID-19 pandemic
April 8, 2020The Covid-19 global pandemic is having a dramatic impact on many chronic conditions including those affecting neurological patients and among them those with movement disorders. In many cases, to protect vulnerable movement disorders patients from becoming infected, appointments have been… Continue Reading -
EAN NewsCOVID-19Top Articles
EAN Scientific Panel Neuroscience/Translational neurology Statement on COVID-19
April 8, 2020Specific challenges at present regarding Covid-19 and how these are being addressed
Highly pathogenic coronavirus infections are well-established sources of previous epidemics (severe acute respiratory syndrome coronavirus: SARS‐CoV, Middle East respiratory syndrome coronavirus: MERS‐CoV). Of interest, the novel coronavirus named… Continue Reading -
Online registration for the EAN Virtual Congress 2020 (May 23-26) is now OPEN!
-
We are excited to announce that we have improved our online community platform, MyEAN!
-
I would like to express my immense gratitude to the European Academy of Neurology for granting me a 12-month research training fellowship. This gave me the opportunity to join the Clinical Neuroimmunology Lab at the University of Basel, under the supervision of Prof. Derfuss. It has been a great honour for me to work in one of the leading multiple sclerosis research groups.
-
Latvia is a scenic country, situated on the shore of Baltic sea in Northern Europe, located between two other Baltic states: Estonia and Lithuania. The name Latvia comes from the ancient tribe called Latgalians who are one of four Indo-European Baltic ancestral tribes which inhabited the region within modern day Lativa. The country has a coastline of more than 500 km along the Baltic Sea, giving everybody the possibility to explore many white sand beaches all year round. More than 50% of the country is filled with precious “green gold” – forests – combined with gorgeous landscapes, rivers and lakes.
-
News from EAN member societiesCOVID-19Top Articles
Frontline Report: Experience from the Spanish Neurologists’ perspective
April 5, 2020Since January 31st, Coronavirus has spread along all the Spanish territory; however, some regions are particularly compromised in terms of number of cases: Madrid, Catalonia, Basque Country and the two Castillian regions. The total number of confirmed cases is about to surpass Italy. We hope to be reaching the plateau of the curve, after all the implemented social distancing measures.